Mitochondrial dynamics in peripheral neuropathies

Antioxidants and Redox Signaling

Volumn 21, Issue 4, 2014, Pages 601-620

  Sajic, Marija ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; DIABETIC NEUROPATHY; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IN VITRO STUDY; MITOCHONDRIAL DYNAMICS; NERVE CELL EXCITABILITY; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; ANIMAL; COMPLICATION; GENETICS; INFLAMMATION; METABOLISM; MITOCHONDRION; PERIPHERAL NERVOUS SYSTEM DISEASES;

ANIMALS; DIABETIC NEUROPATHIES; HUMANS; INFLAMMATION; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84901015809     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5822     Document Type: Review

References (215)

1. Ackerley S, James PA, Kalli A, French S, Davies KE, and Talbot K. A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet 15: 347-354, 2006.
2. Amiott EA, Lott P, Soto J, Kang PB, McCaffery JM, DiMauro S, Abel ED, Flanigan KM, Lawson VH, and Shaw JM. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations. Exp Neurol 211: 115-127, 2008.
3. Auranen M, Ylikallio E, Toppila J, Somer M, Kiuru-Enari S, and Tyynismaa H. Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland. Neurogenetics 14: 123-132, 2013.
4. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, and Bossy-Wetzel E. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25: 3900-3911, 2006.
5. Bartz RR, Suliman HB, Fu P, Welty-Wolf K, Carraway MS, MacGarvey NC, Withers CM, Sweeney TE, and Piantadosi CA. Staphylococcus aureus sepsis and mitochondrial accrual of the 8-oxoguanine DNA glycosylase DNA repair enzyme in mice. Am J Respir Crit Care Med 183: 226-233, 2011.
6. Baxter RV, Ben OK, Rochelle JM, Stajich JE, Hulette C, Dew-Knight S, Hentati F, Ben HM, Bel S, Stenger JE, Gilbert JR, Pericak-Vance MA, and Vance JM. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 30: 21-22, 2002.
7. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, and Marks AR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 15: 325-330, 2009.
8. Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L, and Schiavo G. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci USA 107: 20523-20528, 2010.
9. Bitoun M, Stojkovic T, Prudhon B, Maurage CA, Latour P, Vermersch P, and Guicheney P. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: Clinical and pathological findings. Neuromuscul Disord 18: 334-338, 2008.
10. Bleazard W, McCaffery JM, King EJ, Bale S, Mozdy A, Tieu Q, Nunnari J, and Shaw JM. The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast. Nat Cell Biol 1: 298-304, 1999.
11. Boveris A and Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134: 707-716, 1973.
12. Brinley FJ, Jr. and Tiffert T. Kinetics of calcium accumulation by mitochondria, studied in situ, in squid giant axons. FEBS Lett 91: 25-29, 1978.
13. Brinley FJ, Jr., Tiffert T, and Scarpa A. Mitochondria and other calcium buffers of squid axon studied in situ. J Gen Physiol 72: 101-127, 1978.
14. Britland ST, Young RJ, Sharma AK, and Clarke BF. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 39: 898-908, 1990.
15. Cagalinec M, Safiulina D, Liiv M, Liiv J, Choubey V, Wareski P, Veksler V, and Kaasik A. Principles of the mitochondrial fusion and fission cycle in neurons. J Cell Sci 2013 [Epub ahead of print]; DOI: 10.1242/jcs.118844.
16. Casanova-Molla J, Morales M, Garrabou G, Sola-Valls N, Soriano A, Calvo M, Grau JM, and Valls-Sole J. Mitochondrial loss indicates early axonal damage in small fiber neuropathies. J Peripher Nerv Syst 17: 147-157, 2012.
17. Cassereau J, Chevrollier A, Gueguen N, Malinge MC, Letournel F, Nicolas G, Richard L, Ferre M, Verny C, Dubas F, Procaccio V, Amati-Bonneau P, Bonneau D, and Reynier P. Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K). Neurogenetics 10: 145-150, 2009.
18. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR, and Nunnari J. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 14: 193-204, 2008.
19. Chadan S, Moya KL, Portier MM, and Filliatreau G. Identification of a peripherin dimer: Changes during axonal development and regeneration of the rat sciatic nerve. J Neurochem 62: 1894-1905, 1994.
20. Chadwick W, Boyle JP, Zhou Y, Wang L, Park SS, Martin B, Wang R, Becker KG, Wood WH, Zhang Y, Peers C, and Maudsley S. Multiple oxygen tension environments reveal diverse patterns of transcriptional regulation in primary astrocytes. PLoS One 6: E21638, 2011.
21. Chan NC and Chan DC. Parkin uses the UPS to ship off dysfunctional mitochondria. Autophagy 7: 771-772, 2011.
22. Chang CR and Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 282: 21583-21587, 2007.
23. Chang CR, Manlandro CM, Arnoult D, Stadler J, Posey AE, Hill RB, and Blackstone C. A lethal de novo mutation in the middle domain of the dynamin-related GTPase Drp1 impairs higher order assembly and mitochondrial division. J Biol Chem 285: 32494-32503, 2010.
24. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, and Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160: 189-200, 2003.
25. Chen XJ, Levedakou EN, Millen KJ, Wollmann RL, Soliven B, and Popko B. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene. J Neurosci 27: 14515-14524, 2007.
26. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, and Lipton SA. S-nitrosylation of Drp1 mediates betaamyloid-related mitochondrial fission and neuronal injury. Science 324: 102-105, 2009.
27. Cipolat S, Martins de BO, Dal ZB, and Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci USA 101: 15927-15932, 2004.
28. Claeys KG, Zuchner S, Kennerson M, Berciano J, Garcia A, Verhoeven K, Storey E, Merory JR, Bienfait HM, Lammens M, Nelis E, Baets J, De VE, Berneman ZN, De Veuster I, Vance JM, Nicholson G, Timmerman V, and De JP. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain 132: 1741-1752, 2009.
29. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, and Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 345: 50-54, 1994.
30. Clementi E, Brown GC, Feelisch M, and Moncada S. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95: 7631-7636, 1998.
31. Conforti L, Dell'Agnello C, Calvaresi N, Tortarolo M, Giorgini A, Coleman MP, and Bendotti C. Kif1Bbeta isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res 71: 732-739, 2003.
32. Cotter D, Guda P, Fahy E, and Subramaniam S. Mito-Proteome: Mitochondrial protein sequence database and annotation system. Nucleic Acids Res 32: D463-D467, 2004.
33. Cribbs JT and Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 8: 939-944, 2007.
34. Cuesta A, Pedrola L, Sevilla T, Garcia-Planells J, Chumillas MJ, Mayordomo F, LeGuern E, Marin I, Vilchez JJ, and Palau F. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30: 22-25, 2002.
35. d'Ydewalle C, Krishnan J, Chiheb DM, Van DP, Irobi J, Kozikowski AP, Vanden BP, Timmerman V, Robberecht W, and Van Den BL. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med 17: 968-974, 2011.
36. Dahlin LB, Meiri KF, McLean WG, Rydevik B, and Sjostrand J. Effects of nerve compression on fast axonal transport in streptozotocin-induced diabetes mellitus. An experimental study in the sciatic nerve of rats. Diabetologia 29: 181-185, 1986.
37. Dahlin LB, Stenberg L, Luthman H, and Thomsen NO. Nerve compression induces activating transcription factor 3 in neurons and Schwann cells in diabetic rats. Neuroreport 19: 987-990, 2008.
38. de Brito OM and Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456: 605-610, 2008.
39. de Vos K, Severin F, Van HF, Vancompernolle K, Goossens V, Hyman A, and Grooten J. Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J Cell Biol 149: 1207-1214, 2000.
40. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, and Hamel CP. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26: 207-210, 2000.
41. Delettre C, Lenaers G, Pelloquin L, Belenguer P, and Hamel CP. OPA1 (Kjer type) dominant optic atrophy: A novel mitochondrial disease. Mol Genet Metab 75: 97-107, 2002.
42. Djabali K. Cytoskeletal proteins connecting intermediate filaments to cytoplasmic and nuclear periphery. Histol Histopathol 14: 501-509, 1999.
43. Dombeck DA, Kasischke KA, Vishwasrao HD, Ingelsson M, Hyman BT, and Webb WW. Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy. Proc Natl Acad Sci USA 100: 7081-7086, 2003.
44. Duchen MR. Ca(2 + )-dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons. Biochem J 283 (Pt 1): 41-50, 1992.
45. Dupuis L, Fergani A, Braunstein KE, Eschbach J, Holl N, Rene F, Gonzalez De Aguilar JL, Zoerner B, Schwalenstocker B, Ludolph AC, and Loeffler JP. Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. Exp Neurol 215: 146-152, 2009.
46. Eaton P. Protein thiol oxidation in health and disease: Techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic Biol Med 40: 1889-1899, 2006.
47. Ebenezer GJ, McArthur JC, Thomas D, Murinson B, Hauer P, Polydefkis M, and Griffin JW. Denervation of skin in neuropathies: The sequence of axonal and Schwann cell changes in skin biopsies. Brain 130: 2703-2714, 2007.
48. Elachouri G, Vidoni S, Zanna C, Pattyn A, Boukhaddaoui H, Gaget K, Yu-Wai-Man P, Gasparre G, Sarzi E, Delettre C, Olichon A, Loiseau D, Reynier P, Chinnery PF, Rotig A, Carelli V, Hamel CP, Rugolo M, and Lenaers G. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 21: 12-20, 2011.
49. Elluru RG, Bloom GS, and Brady ST. Fast axonal transport of kinesin in the rat visual system: Functionality of kinesin heavy chain isoforms. Mol Biol Cell 6: 21-40, 1995.
50. Enriquez JA, Fernandez-Silva P, and Montoya J. Autonomous regulation in mammalian mitochondrial DNA transcription. Biol Chem 380: 737-747, 1999.
51. Eura Y, Ishihara N, Yokota S, and Mihara K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J Biochem 134: 333-344, 2003.
52. Evgrafov OV, Mersiyanova I, Irobi J, Van Den BL, Dierick I, Leung CL, Schagina O, Verpoorten N, Van IK, Fedotov V, Dadali E, Auer-Grumbach M, Windpassinger C, Wagner K, Mitrovic Z, Hilton-Jones D, Talbot K, Martin JJ, Vasserman N, Tverskaya S, Polyakov A, Liem RK, Gettemans J, Robberecht W, De JP, and Timmerman V. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 36: 602-606, 2004.
53. Fabrizi GM, Cavallaro T, Angiari C, Bertolasi L, Cabrini I, Ferrarini M, and Rizzuto N. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology 62: 1429-1431, 2004.
54. Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G, Bertolasi L, and Rizzuto N. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain 130: 394-403, 2007.
55. Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, and Rizzuto N. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology 69: 291-295, 2007.
56. Fasman KH, Letovsky SI, Cottingham RW, and Kingsbury DT. Improvements to the GDB Human Genome Data Base. Nucleic Acids Res 24: 57-63, 1996.
57. Feely SM, Laura M, Siskind CE, Sottile S, Davis M, Gibbons VS, Reilly MM, and Shy ME. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 76: 1690-1696, 2011.
58. Foster TS. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ 33: 111-117, 2007.
59. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, and Youle RJ. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1: 515-525, 2001.
60. Fressinaud C and Dubas F. Axon cytoskeleton ultrastructure in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 44: 332-339, 2011.
61. Frieden M, James D, Castelbou C, Danckaert A, Martinou JC, and Demaurex N. Ca(2 + ) homeostasis during mitochondrial fragmentation and perinuclear clustering induced by hFis1. J Biol Chem 279: 22704-22714, 2004.
62. Gandre-Babbe S and van der Bliek AM. The novel tailanchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. Mol Biol Cell 19: 2402-2412, 2008.
63. Garcia ML, Rao MV, Fujimoto J, Garcia VB, Shah SB, Crum J, Gotow T, Uchiyama Y, Ellisman M, Calcutt NA, and Cleveland DW. Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J Neurosci 29: 1277-1284, 2009.
64. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, and Taanman JW. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19: 4861-4870, 2010.
65. Gentil BJ, Minotti S, Beange M, Baloh RH, Julien JP, and Durham HD. Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease. FASEB J 26: 1194-1203, 2012.
66. Germain M, Mathai JP, McBride HM, and Shore GC. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J 24: 1546-1556, 2005.
67. Gilbert HF. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol 251: 8-28, 1995.
68. Guillet V, Gueguen N, Verny C, Ferre M, Homedan C, Loiseau D, Procaccio V, Amati-Bonneau P, Bonneau D, Reynier P, and Chevrollier A. Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease. Neurogenetics 11: 127-133, 2010.
69. Haberlova J, Mazanec R, Ridzon P, Barankova L, Nurnberg G, Nurnberg P, Sticht H, Huehne K, Seeman P, and Rautenstrauss B. Phenotypic variability in a large Czech family with a dynamin 2-associated Charcot-Marie-Tooth neuropathy. J Neurogenet 25: 182-188, 2011.
70. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, Lalli G, Witherden AS, Hummerich H, Nicholson S, Morgan PJ, Oozageer R, Priestley JV, Averill S, King VR, Ball S, Peters J, Toda T, Yamamoto A, Hiraoka Y, Augustin M, Korthaus D, Wattler S, Wabnitz P, Dickneite C, Lampel S, Boehme F, Peraus G, Popp A, Rudelius M, Schlegel J, Fuchs H, Hrabe de Angelis M, Schiavo G, Shima DT, Russ AP, Stumm G, Martin JE, and Fisher EM. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300: 808-812, 2003.
71. Harati Y. Diabetic neuropathies: Unanswered questions. Neurol Clin 25: 303-317, 2007.
72. Hirokawa N, Niwa S, and Tanaka Y. Molecular motors in neurons: Transport mechanisms and roles in brain function, development, and disease. Neuron 68: 610-638, 2010.
73. Hirokawa N, Sato-Yoshitake R, Kobayashi N, Pfister KK, Bloom GS, and Brady ST. Kinesin associates with anterogradely transported membranous organelles in vivo. J Cell Biol 114: 295-302, 1991.
74. Hirokawa N and Takemura R. Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci 6: 201-214, 2005.
75. Hollenbeck PJ and Saxton WM. The axonal transport of mitochondria. J Cell Sci 118: 5411-5419, 2005.
76. Hua W, Young EC, Fleming ML, and Gelles J. Coupling of kinesin steps to ATP hydrolysis. Nature 388: 390-393, 1997.
77. Huber N, Guimaraes S, Schrader M, Suter U, and Niemann A. Charcot-Marie-Tooth disease-associated mutants of GDAP1 dissociate its roles in peroxisomal and mitochondrial fission. EMBO Rep 14: 545-552, 2013.
78. Ilieva HS, Yamanaka K, Malkmus S, Kakinohana O, Yaksh T, Marsala M, and Cleveland DW. Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc Natl Acad Sci USA 105: 12599-12604, 2008.
79. Illes Z, Shimamura M, Newcombe J, Oka N, and Yamamura T. Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol 16: 223-230, 2004.
80. Ingerman E, Perkins EM, Marino M, Mears JA, McCaffery JM, Hinshaw JE, and Nunnari J. Dnm1 forms spirals that are structurally tailored to fit mitochondria. J Cell Biol 170: 1021-1027, 2005.
81. Irobi J, Almeida-Souza L, Asselbergh B, De Winter V, Goethals S, Dierick I, Krishnan J, Timmermans JP, Robberecht W, De JP, Van Den BL, Janssens S, and Timmerman V. Mutant HSPB8 causes motor neuron-specific neurite degeneration. Hum Mol Genet 19: 3254-3265, 2010.
82. Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki SO, Masuda K, Otera H, Nakanishi Y, Nonaka I, Goto Y, Taguchi N, Morinaga H, Maeda M, Takayanagi R, Yokota S, and Mihara K. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 11: 958-966, 2009.
83. Jordanova A, De JP, Boerkoel CF, Takashima H, De VE, Ceuterick C, Martin JJ, Butler IJ, Mancias P, Papasozomenos SC, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, and Timmerman V. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126: 590-597, 2003.
84. Kabzinska D, Niemann A, Drac H, Huber N, Potulska-Chromik A, Hausmanowa-Petrusewicz I, Suter U, and Kochanski A. A new missense GDAP1 mutation disturbing targeting to the mitochondrial membrane causes a severe form of AR-CMT2C disease. Neurogenetics 12: 145-153, 2011.
85. Karbowski M, Arnoult D, Chen H, Chan DC, Smith CL, and Youle RJ. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 164: 493-499, 2004.
86. Karki S and Holzbaur EL. Cytoplasmic dynein and dynactin in cell division and intracellular transport. Curr Opin Cell Biol 11: 45-53, 1999.
87. Kennedy WR, Wendelschafer-Crabb G, and Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47: 1042-1048, 1996.
88. Kim H, Scimia MC, Wilkinson D, Trelles RD, Wood MR, Bowtell D, Dillin A, Mercola M, and Ronai ZA. Finetuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell 44: 532-544, 2011.
89. Kim I, Rodriguez-Enriquez S, and Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462: 245-253, 2007.
90. Klein CJ, Kimmel GW, Pittock SJ, Engelstad JE, Cunningham JM, Wu Y, and Dyck PJ. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol 68: 1295-1302, 2011.
91. Kostenko S, Johannessen M, and Moens U. PKA-induced F-actin rearrangement requires phosphorylation of Hsp27 by the MAPKAP kinase MK5. Cell Signal 21: 712-718, 2009.
92. Koutsopoulos OS, Koch C, Tosch V, Bohm J, North KN, and Laporte J. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy. PLoS One 6: E27498, 2011.
93. Kruman II and Mattson MP. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J Neurochem 72: 529-540, 1999.
94. Kuijpers M and Hoogenraad CC. Centrosomes, microtubules and neuronal development. Mol Cell Neurosci 48: 349-358, 2011.
95. Lalli G and Schiavo G. Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neurotrophin receptor p75NTR. J Cell Biol 156: 233-239, 2002.
96. Lane P, Hao G, and Gross SS. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: Head-to-head comparison with O-phosphorylation. Sci STKE 2001: Re1, 2001.
97. Lawson VH, Graham BV, and Flanigan KM. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 65: 197-204, 2005.
98. Leapman RD, Gallant PE, Reese TS, and Andrews SB. Phosphorylation and subunit organization of axonal neurofilaments determined by scanning transmission electron microscopy. Proc Natl Acad Sci USA 94: 7820-7824, 1997.
99. Lee YJ, Jeong SY, Karbowski M, Smith CL, and Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15: 5001-5011, 2004.
100. Lehmann HC, Kohne A, Meyer Zu HG, Dehmel T, Kiehl O, Hartung HP, Kastenbauer S, and Kieseier BC. Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies. J Neuropathol Exp Neurol 66: 305-312, 2007.
101. Lennertz RC, Medler KA, Bain JL, Wright DE, and Stucky CL. Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy. J Neurophysiol 106: 905-914, 2011.
102. Leterrier JF, Rusakov DA, Nelson BD, and Linden M. Interactions between brain mitochondria and cytoskeleton: Evidence for specialized outer membrane domains involved in the association of cytoskeleton-associated proteins to mitochondria in situ and in vitro. Microsc Res Tech 27: 233-261, 1994.
103. Levy JR and Holzbaur EL. Cytoplasmic dynein/dynactin function and dysfunction in motor neurons. Int J Dev Neurosci 24: 103-111, 2006.
104. Lewis RM and Lewis WH. Mitochondria (and other cytoplasmic structures) in tissue cultures. Science 17: 340-401, 1915.
105. Li Z, Okamoto K, Hayashi Y, and Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119: 873-887, 2004.
106. Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, and Watkins PJ. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 114 (Pt 2): 867-892, 1991.
107. Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E, Barboni P, Longanesi L, Schimpf S, Wissinger B, Baruzzi A, Barbiroli B, and Carelli V. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol 56: 719-723, 2004.
108. Loiseau D, Chevrollier A, Verny C, Guillet V, Gueguen N, Pou de Crescenzo MA, Ferre M, Malinge MC, Guichet A, Nicolas G, Amati-Bonneau P, Malthiery Y, Bonneau D, and Reynier P. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol 61: 315-323, 2007.
109. Loson OC, Song Z, Chen H, and Chan DC. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell 24: 659-667, 2013.
110. Lowes DA, Webster NR, Murphy MP, and Galley HF. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth 110: 472-480, 2013.
111. Mallik R, Petrov D, Lex SA, King SJ, and Gross SP. Building complexity: An in vitro study of cytoplasmic dynein with in vivo implications. Curr Biol 15: 2075-2085, 2005.
112. Martin M, Iyadurai SJ, Gassman A, Gindhart JG, Jr., Hays TS, and Saxton WM. Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport. Mol Biol Cell 10: 3717-3728, 1999.
113. Mayer JH and Tomlinson DR. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25: 433-438, 1983.
114. McCorquodale DS, III, Montenegro G, Peguero A, Carlson N, Speziani F, Price J, Taylor SW, Melanson M, Vance JM, and Zuchner S. Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2. J Neurol 258: 1234-1239, 2011.
115. Medori R, Autilio-Gambetti L, Monaco S, and Gambetti P. Experimental diabetic neuropathy: Impairment of slow transport with changes in axon cross-sectional area. Proc Natl Acad Sci USA 82: 7716-7720, 1985.
116. Merrill RA, Dagda RK, Dickey AS, Cribbs JT, Green SH, Usachev YM, and Strack S. Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1. PLoS Biol 9: E1000612, 2011.
117. Milenkovic D, Matic S, Kuhl I, Ruzzenente B, Freyer C, Jemt E, Park CB, Falkenberg M, and Larsson NG TWINKLE is an essential mitochondrial helicase required for synthesis of nascent D-loop strands and complete mtDNA replication. Hum Mol Genet 22: 1983-1993, 2013.
118. Millecamps S, Gowing G, Corti O, Mallet J, and Julien JP. Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments. J Neurosci 27: 4947-4956, 2007.
119. Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, Timmerman V, Windpassinger C, Auer-Grumbach M, and Loscher WN. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene. Arch Neurol 64: 966-970, 2007.
120. Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, and Lichtman JW. Imaging axonal transport of mitochondria in vivo. Nat Methods 4: 559-561, 2007.
121. Misko A, Jiang S, Wegorzewska I, Milbrandt J, and Baloh RH. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 30: 4232-4240, 2010.
122. Miyakawa T, Murayama E, Sumiyoshi S, Deshimaru M, and Kamano A. A biopsy case of Landry-Guillain-Barre syndrome. Acta Neuropathol 17: 181-187, 1971.
123. Motil J, Chan WK, Dubey M, Chaudhury P, Pimenta A, Chylinski TM, Ortiz DT, and Shea TB. Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: Regulation by multiple phosphorylation events. Cell Motil Cytoskeleton 63: 266-286, 2006.
124. Muglia M, Vazza G, Patitucci A, Milani M, Pareyson D, Taroni F, Quattrone A, and Mostacciuolo ML. A novel founder mutation in the MFN2 gene associated with variable Charcot-Marie-Tooth type 2 phenotype in two families from Southern Italy. J Neurol Neurosurg Psychiatry 78: 1286-1287, 2007.
125. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
126. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H, and Hirokawa N. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79: 1209-1220, 1994.
127. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJ, and Ward JD. Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) 293: 1053-1054, 1986.
128. Nicholson GA, Magdelaine C, Zhu D, Grew S, Ryan MM, Sturtz F, Vallat JM, and Ouvrier RA. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations. Neurology 70: 1678-1681, 2008.
129. Nicoziani P, Vilhardt F, Llorente A, Hilout L, Courtoy PJ, Sandvig K, and van Deurs B. Role for dynamin in late endosome dynamics and trafficking of the cationindependent mannose 6-phosphate receptor. Mol Biol Cell 11: 481-495, 2000.
130. Niemann A, Ruegg M, La Padula V, Schenone A, and Suter U. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: New implications for Charcot-Marie-Tooth disease. J Cell Biol 170: 1067-1078, 2005.
131. Niemann A, Wagner KM, Ruegg M, and Suter U. GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol Dis 36: 509-520, 2009.
132. Niven JE and Laughlin SB. Energy limitation as a selective pressure on the evolution of sensory systems. J Exp Biol 211: 1792-1804, 2008.
133. Nixon RA and Lewis SE. Differential turnover of phosphate groups on neurofilament subunits in mammalian neurons in vivo. J Biol Chem 261: 16298-16301, 1986.
134. Noack R, Frede S, Albrecht P, Henke N, Pfeiffer A, Knoll K, Dehmel T, Meyer Zu HG, Stettner M, Kieseier BC, Summer H, Golz S, Kochanski A, Wiedau-Pazos M, Arnold S, Lewerenz J, and Methner A. Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential. Hum Mol Genet 21: 150-162, 2012.
135. Noble F, Rubira E, Boulanouar M, Palmier B, Plotkine M, Warnet JM, Marchand-Leroux C, and Massicot F. Acute systemic inflammation induces central mitochondrial damage and mnesic deficit in adult Swiss mice. Neurosci Lett 424: 106-110, 2007.
136. Obrosova IG and Julius UA. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy. Curr Vasc Pharmacol 3: 267-283, 2005.
137. Ohno N, Kidd GJ, Mahad D, Kiryu-Seo S, Avishai A, Komuro H, and Trapp BD. Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J Neurosci 31: 7249-7258, 2011.
138. Ori-McKenney KM, Xu J, Gross SP, and Vallee RB. A cytoplasmic dynein tail mutation impairs motor processivity. Nat Cell Biol 12: 1228-1234, 2010.
139. Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ, and Mihara K. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol 191: 1141-1158, 2010.
140. Palmer CS, Osellame LD, Laine D, Koutsopoulos OS, Frazier AE, and Ryan MT. MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep 12: 565-573, 2011.
141. Pedrola L, Espert A, Wu X, Claramunt R, Shy ME, and Palau F. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum Mol Genet 14: 1087-1094, 2005.
142. Perng MD, Cheng TJ, Chen CM, and Lai YK. Induction of aggregation and augmentation of protein kinase-mediated phosphorylation of purified vimentin intermediate filaments by withangulatin A. Mol Pharmacol 46: 612-617, 1994.
143. Perng MD, Wen SF, van den Ijssel P, Prescott AR, and Quinlan RA. Desmin aggregate formation by R120G alphaB-crystallin is caused by altered filament interactions and is dependent upon network status in cells. Mol Biol Cell 15: 2335-2346, 2004.
144. Perrot R and Julien JP. Real-time imaging reveals defects of fast axonal transport induced by disorganization of intermediate filaments. FASEB J 23: 3213-3225, 2009.
145. Pesch UE, Leo-Kottler B, Mayer S, Jurklies B, Kellner U, Apfelstedt-Sylla E, Zrenner E, Alexander C, and Wissinger B. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet 10: 1359-1368, 2001.
146. Pfister KK, Shah PR, Hummerich H, Russ A, Cotton J, Annuar AA, King SM, and Fisher EM. Genetic analysis of the cytoplasmic dynein subunit families. PLoS Genet 2: E1, 2006.
147. Pilling AD, Horiuchi D, Lively CM, and Saxton WM. Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons. Mol Biol Cell 17: 2057-2068, 2006.
148. Pla-Martin D, Rueda CB, Estela A, Sanchez-Piris M, Gonzalez-Sanchez P, Traba J, de la FS, Scorrano L, Renau-Piqueras J, Alvarez J, Satrustegui J, and Palau F. Silencing of the Charcot-Marie-Tooth disease-associated gene GDAP1 induces abnormal mitochondrial distribution and affects Ca(2 + ) homeostasis by reducing store-operated Ca(2 + ) entry. Neurobiol Dis 55: 140-151, 2013.
149. Poole AC, Thomas RE, Yu S, Vincow ES, and Pallanck L. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One 5: E10054, 2010.
150. Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, Graham FL, Gaskell PC, Dearlove A, Pericak-Vance MA, Rubinsztein DC, and Marchuk DA. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71: 1189-1194, 2002.
151. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, Tuft RA, and Pozzan T. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2 + responses. Science 280: 1763-1766, 1998.
152. Rizzuto R, Simpson AW, Brini M, and Pozzan T. Rapid changes of mitochondrial Ca2 + revealed by specifically targeted recombinant aequorin. Nature 358: 325-327, 1992.
153. Ropp PA and Copeland WC. Cloning and characterization of the human mitochondrial DNA polymerase, DNA polymerase gamma. Genomics 36: 449-458, 1996.
154. Ross JL, Wallace K, Shuman H, Goldman YE, and Holzbaur EL. Processive bidirectional motion of dyneindynactin complexes in vitro. Nat Cell Biol 8: 562-570, 2006.
155. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, and Feldman EL. High glucoseinduced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16: 1738-1748, 2002.
156. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, and Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6: 347-363, 1999.
157. Said G. Focal and multifocal diabetic neuropathies. Arq Neuropsiquiatr 65: 1272-1278, 2007.
158. Saito M, Hayashi Y, Suzuki T, Tanaka H, Hozumi I, and Tsuji S. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology 49: 1630-1635, 1997.
159. Sajic M, Mastrolia V, Lee CY, Trigo D, Sadeghian M, et al. Impulse conduction increases mitochondrial transport in adult mammalian peripheral nerves in vivo. PLoS Biol 2013 [Epub ahead of print]; DOI:10.1371/journal .pbio.1001754.
160. Schmeichel AM, Schmelzer JD, and Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52: 165-171, 2003.
161. Schnitzer MJ and Block SM. Kinesin hydrolyses one ATP per 8-nm step. Nature 388: 386-390, 1997.
162. Sebastian D, Hernandez-Alvarez MI, Segales J, Sorianello E, Munoz JP, Sala D, Waget A, Liesa M, Paz JC, Gopalacharyulu P, Oresic M, Pich S, Burcelin R, Palacin M, and Zorzano A. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci USA 109: 5523-5528, 2012.
163. Shah JV, Flanagan LA, Janmey PA, and Leterrier JF. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol Biol Cell 11: 3495-3508, 2000.
164. Shriver LP and Dittel BN. T-cell-mediated disruption of the neuronal microtubule network: Correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. Am J Pathol 169: 999-1011, 2006.
165. Sihag RK, Inagaki M, Yamaguchi T, Shea TB, and Pant HC. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp Cell Res 313: 2098-2109, 2007.
166. Slupe AM, Merrill RA, Flippo KH, Lobas MA, Houtman JC, and Strack S. A calcineurin docking motif (LXVP) in dynamin-related protein 1 contributes to mitochondrial fragmentation and ischemic neuronal injury. J Biol Chem 288: 12353-12365, 2013.
167. Smirnova E, Griparic L, Shurland DL and van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12: 2245-2256, 2001.
168. Smirnova E, Shurland DL, Ryazantsev SNand van der Bliek AM. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 143: 351-358, 1998.
169. Smith AG and Singleton JR. Diabetic neuropathy. Continuum (Minneap Minn) 18: 60-84, 2012.
170. Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N, Comi G, Morandi L, Santoro L, Toscano A, Fabrizi GM, Somer H, Croxen R, Beeson D, Poulton J, Suomalainen A, Jacobs HT, Zeviani M, and Larsson C. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28: 223-231, 2001.
171. Srinivasan S, Stevens M, and Wiley JW. Diabetic peripheral neuropathy: Evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49: 1932-1938, 2000.
172. Stojanovski D, Koutsopoulos OS, Okamoto K, and Ryan MT. Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology. J Cell Sci 117: 1201-1210, 2004.
173. Strack S and Cribbs JT. Allosteric modulation of Drp1 mechanoenzyme assembly and mitochondrial fission by the variable domain. J Biol Chem 287: 10990-11001, 2012.
174. Taguchi N, Ishihara N, Jofuku A, Oka T, and Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 282: 11521-11529, 2007.
175. Telci A, Cakatay U, Salman S, Satman I, and Sivas A. Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res Clin Pract 50: 213-223, 2000.
176. Terao E, Janssens S, van den Bosch de Aguilar, Portier M, and Klosen P. In vivo expression of the intermediate filament peripherin in rat motoneurons: Modulation by inhibitory and stimulatory signals. Neuroscience 101: 679-688, 2000.
177. Theiss C, Napirei M, and Meller K. Impairment of anterograde and retrograde neurofilament transport after anti-kinesin and anti-dynein antibody microinjection in chicken dorsal root ganglia. Eur J Cell Biol 84: 29-43, 2005.
178. Tomlinson DR and Mayer JH. Defects of axonal transport in diabetes mellitus-a possible contribution to the aetiology of diabetic neuropathy. J Auton Pharmacol 4: 59-72, 1984.
179. Tsurusaki Y, Saitoh S, Tomizawa K, Sudo A, Asahina N, Shiraishi H, Ito J, Tanaka H, Doi H, Saitsu H, Miyake N, and Matsumoto N. A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics 13: 327-332, 2012.
180. Twig G, Graf SA, Wikstrom JD, Mohamed H, Haigh SE, Elorza A, Deutsch M, Zurgil N, Reynolds N, and Shirihai OS. Tagging and tracking individual networks within a complex mitochondrial web with photoactivatable GFP. Am J Physiol Cell Physiol 291: C176-C184, 2006.
181. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, and Lipton SA. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517, 2006.
182. Vale RD, Reese TS, and Sheetz MP. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell 42: 39-50, 1985.
183. Vanasco V, Magnani ND, Cimolai MC, Valdez LB, Evelson P, Boveris A, and Alvarez S. Endotoxemia impairs heart mitochondrial function by decreasing electron transfer, ATP synthesis and ATP content without affecting membrane potential. J Bioenerg Biomembr 44: 243-252, 2012.
184. Varadi A, Cirulli V, and Rutter GA. Mitochondrial localization as a determinant of capacitative Ca2 + entry in HeLa cells. Cell Calcium 36: 499-508, 2004.
185. Verhoeven K, Claeys KG, Zuchner S, Schroder JM, Weis J, Ceuterick C, Jordanova A, Nelis E, De VE, Van HM, Seeman P, Mazanec R, Saifi GM, Szigeti K, Mancias P, Butler IJ, Kochanski A, Ryniewicz B, De BJ, Van den BP, Verellen C, Van CR, Goemans N, Auer-Grumbach M, Robberecht W, Milic Rasic V, Nevo Y, Tournev I, Guergueltcheva V, Roelens F, Vieregge P, Vinci P, Moreno MT, Christen HJ, Shy ME, Lupski JR, Vance JM, De JP, and Timmerman V. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129: 2093-2102, 2006.
186. Verity MA and Gambell JK. Studies of copper ion-induced mitochondrial swelling in vitro. Biochem J 108: 289-295, 1968.
187. Veves A, Malik RA, Lye RH, Masson EA, Sharma AK, Schady W, and Boulton AJ. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabet Med 8: 917-921, 1991.
188. Vincent AM, Edwards JL, McLean LL, Hong Y, Cerri F, Lopez I, Quattrini A, and Feldman EL. Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol 120: 477-489, 2010.
189. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, and Feldman EL. Dyslipidemia-induced neuropathy in mice: The role of oxLDL/LOX-1. Diabetes 58: 2376-2385, 2009.
190. Vincent AM, McLean LL, Backus C, and Feldman EL. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 19: 638-640, 2005.
191. Vital A and Vital C. Mitochondria and peripheral neuropathies. J Neuropathol Exp Neurol 71: 1036-1046, 2012.
192. Wagner OI, Lifshitz J, Janmey PA, Linden M, McIntosh TK, and Leterrier JF. Mechanisms of mitochondria-neurofilament interactions. J Neurosci 23: 9046-9058, 2003.
193. Wang X and Schwarz TL. The mechanism of Ca2 +-dependent regulation of kinesin-mediated mitochondrial motility. Cell 136: 163-174, 2009.
194. Wanschitz J, Maier H, Lassmann H, Budka H, and Berger T. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome. Brain 126: 2034-2042, 2003.
195. Weedon MN, Hastings R, Caswell R, Xie W, Paszkiewicz K, Antoniadi T, Williams M, King C, Greenhalgh L, Newbury-Ecob R, and Ellard S. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 89: 308-312, 2011.
196. Wei YH and Lee HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med (Maywood) 227: 671-682, 2002.
197. Wiggins LM, Kuta A, Stevens JC, Fisher EM, and von Bartheld CS. A novel phenotype for the dynein heavy chain mutation Loa: Altered dendritic morphology, organelle density, and reduced numbers of trigeminal motoneurons. J Comp Neurol 520: 2757-2773, 2012.
198. Willemsen MH, Vissers LE, Willemsen MA, van Bon BW, Kroes T, de Ligt J, de Vries BB, Schoots J, Lugtenberg D, Hamel BC, van Bokhoven H, Brunner HG, Veltman JA, and Kleefstra T. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J Med Genet 49: 179-183, 2012.
199. Winer J, Hughes S, Cooper J, Ben-Smith A, and Savage C. gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy. J Neurol 249: 616-621, 2002.
200. Wisniewski H, Terry RD, Whitaker JN, Cook SD, and Dowling PC. Landry-Guillain-Barre syndrome. A primary demyelinating disease. Arch Neurol 21: 269-276, 1969.
201. Wozniak MJ, Melzer M, Dorner C, Haring HU, and Lammers R. The novel protein KBP regulates mitochondria localization by interaction with a kinesin-like protein. BMC Cell Biol 6: 35, 2005.
202. Yabe JT, Pimenta A, and Shea TB. Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J Cell Sci 112 (Pt 21): 3799-3814, 1999.
203. Yi M, Weaver D, and Hajnoczky G. Control of mitochondrial motility and distribution by the calcium signal: A homeostatic circuit. J Cell Biol 167: 661-672, 2004.
204. Yoshihara T, Yamamoto M, Hattori N, Misu K, Mori K, Koike H, and Sobue G. Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: Analysis of Charcot-Marie-Tooth disease patients and normal individuals. J Peripher Nerv Syst 7: 221-224, 2002.
205. Yum SW, Zhang J, Mo K, Li J, and Scherer SS. A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy. Ann Neurol 66: 759-770, 2009.
206. Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, and Carelli V. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 131: 352-367, 2008.
207. Zhai J, Lin H, Julien JP, and Schlaepfer WW. Disruption of neurofilament network with aggregation of light neurofilament protein: A common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth diseaselinked mutations in NFL and HSPB1. Hum Mol Genet 16: 3103-3116, 2007.
208. Zhang CL, Ho PL, Kintner DB, Sun D, and Chiu SY. Activity-dependent regulation of mitochondrial motility by calcium and Na/K-ATPase at nodes of Ranvier of myelinated nerves. J Neurosci 30: 3555-3566, 2010.
209. Zhang CL, Rodenkirch L, Schultz JR, and Chiu SY. A novel method to study the local mitochondrial fusion in myelinated axons in vivo. J Neurosci Methods 207: 51-58, 2012.
210. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, and Hirokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105: 587-597, 2001.
211. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, and Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial. Diabetes Care 29: 2365-2370, 2006.
212. Zimon M, Baets J, Fabrizi GM, Jaakkola E, Kabzinska D, Pilch J, Schindler AB, Cornblath DR, Fischbeck KH, Auer-Grumbach M, Guelly C, Huber N, De VE, Timmerman V, Suter U, Hausmanowa-Petrusewicz I, Niemann A, Kochanski A, De JP, and Jordanova A. Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology 77: 540-548, 2011.
213. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schroder JM, and Vance JM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36: 449-451, 2004.
214. Zuchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, De JP, Merory J, Oliveira SA, Speer MC, Stenger JE, Walizada G, Zhu D, Pericak-Vance MA, Nicholson G, Timmerman V, and Vance JM. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 37: 289-294, 2005.
215. Zuchner S, Vorgerd M, Sindern E, and Schroder JM. The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy. Neuromuscul Disord 14: 147-157, 2004.